IP Library Patent Application 12467122
Patent Application
App. No. 12/467,122

TISSUE MODIFICATION DEVICES AND METHODS OF THE SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/467,122
Abstract

Tissue modification devices are provided. Aspects of the devices include an elongated member having a proximal end and a distal end, an tissue modifier positioned at the distal end, and a linear mechanical actuator configured to linearly translate the RF electrode relative the distal end according to a linear translation waveform. The devices may be configured to operate the tissue modifier according to an operating waveform that is synchronized with the linear translation waveform. Also provided are methods of modifying an internal target tissue of a subject using the tissue modification devices.

Claims (31)

1 . A tissue modification device comprising:

an elongated member having a proximal end and a distal end;

a tissue modifier positioned at the distal end; and

a linear mechanical actuator configured to linearly translate the tissue modifier relative the distal end according to a linear translation waveform.

2 . The tissue modification device according to claim 1 , wherein the device further synchronizes the linear translation waveform with a tissue modifier operating waveform.

3 . The tissue modification device according to claim 2 , wherein the tissue modifier operating waveform is phase shifted relative to the linear translation waveform.

4 . The tissue modification device according to claim 1 , wherein the linear translation waveform has a frequency that is 10 Hz or greater.

5 . The tissue modification device according to claim 1 , wherein the tissue modifier is a RF electrode.

6 . The tissue modification device according to claim 5 , wherein the RF electrode has an operating waveform that is definable as KHz waveform modulated with an Hz waveform.

7 . The tissue modification device according to claim 1 , wherein the device comprises a sensor configured to obtain linear translation waveform data.

8 . The tissue modification device according to claim 7 , wherein the obtained linear translation waveform data is used to synchronize an operating waveform of the tissue modifier with the linear translation waveform.

9 . The tissue modification device according to claim 7 , wherein the sensor is a sensor selected from the group consisting of an optical encoder, mechanical encoder, optoelectronic sensor, and Hall effect sensor.

10 . The tissue modification device according to claim 1 , wherein the linear mechanical actuator is selected from a voice-coil, a solenoid and an electric motor.

11 . The tissue modification device according to claim 1 , wherein the device further comprises a distal end visualization sensor.

12 . The tissue modification device according to claim 11 , wherein the visualization sensor is selected from a CCD and CMOS sensor.

13 . The tissue modification device according to claim 1 , wherein the device is configured for distal end steerability.

14 . The tissue modification device according to claim 1 , wherein the device further comprises a distal end irrigator and aspirator.

15 . The tissue modification device according to claim 1 , wherein the distal end of the elongated member is dimensioned to access an intervertebral disc.

16 . A method of modifying an internal target tissue of a subject, the method comprising:

(a) positioning a tissue modification device comprising:

(i) an elongated member having a proximal end and a distal end;

(ii) a tissue modifier positioned at the distal end; and

(iii) a linear mechanical actuator configured to linearly translate the tissue modifier relative the distal end according to a linear translation waveform;

in operative relationship to the internal target tissue; and

(b) modifying the internal target tissue with the tissue modifier.

17 . the method according to claim 16 , wherein the tissue modifier comprises a RF electrode and the method comprises delivering RF energy to the internal target tissue in a manner effective to modify the internal target tissue of the subject.

18 . The method according to claim 16 , wherein the method comprises operating the linear translation actuator at a frequency of 10 Hz or greater.

19 . The method according to claim 17 , wherein the energy delivered by the tissue modification device is modulated by a modulation waveform that is synchronized with the linear translation waveform to provide the tissue modifier with capability for tissue discrimination based on elastic modulus.

20 . The method according to claim 16 , wherein the tissue modification device further comprises a visualization element located at the distal end of the elongated member, and the method comprises visualizing the internal target tissue site.

21 . The method according to claim 16 , wherein the internal target tissue comprises spinal tissue.

22 . The method according to claim 16 , wherein the method further comprises discriminating between internal tissue types.

Assignments (2)
SECURITY AGREEMENT Recorded Jul 6, 2011
From: AXIS SURGICAL TECHNOLOGIES, INC.
To: BIOSTAR VENTURES II, L.P., AS COLLATERAL AGENT
Reel/Frame 026552/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2009
From: CYBULSKI, JAMES S.; SCHULTZ, ERIC E.; SEDDIQUI, FRED R.
To: AXIS SURGICAL TECHNOLOGIES INC.
Reel/Frame 022800/0348 →